Bergmann, Juri, Mueller, Miryam, Baumann, Niklas, Reichert, Manuel, Heneweer, Carola, Bolik, Julia, Luecke, Karsten, Gruber, Sabine, Carambia, Antonella, Boretius, Susanne, Leuschner, Ivo, Becker, Thomas, Rabe, Bjoern, Herkel, Johannes ORCID: 0000-0001-9055-9999, Wunderlich, F. Thomas, Mittruecker, Hans-Willi, Rose-John, Stefan ORCID: 0000-0002-7519-3279 and Schmidt-Arras, Dirk ORCID: 0000-0002-1072-7495 (2017). IL-6 Trans-Signaling Is Essential for the Development of Hepatocellular Carcinoma in Mice. Hepatology, 65 (1). S. 89 - 104. HOBOKEN: WILEY. ISSN 1527-3350

Full text not available from this repository.

Abstract

Hepatocellular carcinoma (HCC) is one of the most frequent tumors worldwide with rising incidence. The inflammatory cytokine, interleukin-6 (IL-6), is a critical mediator of HCC development. It can signal through two distinct pathways: the IL-6 classic and the IL-6 trans-signaling pathway. Whereas IL-6 classic signaling is important for innate and acquired immunity, IL-6 trans-signaling has been linked to accelerated liver regeneration and several chronic inflammatory pathologies. However, its implication in liver tumorigenesis has not been addressed yet. Here, we show that IL-6 trans-signaling, but not IL-6 classic signaling, is essential to promote hepatocellular carcinogenesis by two mechanisms: First, it prevents DNA-damage-induced hepatocyte apoptosis through suppression of p53 and enhances beta-catenin activation and tumor proliferation. Second, IL-6 trans-signaling directly induces endothelial cell proliferation to promote tumor angiogenesis. Consequently, soluble gp130 fused to Fc transgenic mice lacking IL-6 trans-signaling are largely protected from tumor formation in a diethylnitrosamine/3,3',5,5'-tetrachloro-1,4-bis(pyridyloxy) benzene model of HCC. Conclusion: IL-6 trans-signaling, and not IL-6 classic signaling, is mandatory for development of hepatocellular carcinogenesis. Therefore, specific inhibition of IL-6 trans-signaling, rather than total inhibition of IL-6 signaling, is sufficient to blunt tumor initiation and impair tumor progression without compromising IL-6 classic signaling-driven protective immune responses.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Bergmann, JuriUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mueller, MiryamUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Baumann, NiklasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reichert, ManuelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heneweer, CarolaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bolik, JuliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Luecke, KarstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gruber, SabineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Carambia, AntonellaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boretius, SusanneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Leuschner, IvoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Becker, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rabe, BjoernUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Herkel, JohannesUNSPECIFIEDorcid.org/0000-0001-9055-9999UNSPECIFIED
Wunderlich, F. ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mittruecker, Hans-WilliUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rose-John, StefanUNSPECIFIEDorcid.org/0000-0002-7519-3279UNSPECIFIED
Schmidt-Arras, DirkUNSPECIFIEDorcid.org/0000-0002-1072-7495UNSPECIFIED
URN: urn:nbn:de:hbz:38-243437
DOI: 10.1002/hep.28874
Journal or Publication Title: Hepatology
Volume: 65
Number: 1
Page Range: S. 89 - 104
Date: 2017
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1527-3350
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
LIVER-CANCER; P53; INTERLEUKIN-6; CATENIN; PROTEIN; CIRRHOSIS; CYTOKINE; COMPLEX; TUMORIGENESIS; INFLAMMATIONMultiple languages
Gastroenterology & HepatologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/24343

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item